{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:27Z","timestamp":1791295287659,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cytogfr.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T02:16:24Z","timestamp":1371521784000},"page":"477-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The therapeutic potential of blocking the activin signalling pathway"],"prefix":"10.1016","volume":"24","author":[{"given":"Francesco Elia","family":"Marino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Risbridger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/rep.1.01073","article-title":"Pituitary actions of ligands of the TGF-\u03b2 family: activins and inhibins","volume":"132","author":"Bilezikjian","year":"2006","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-\u03b2 signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annual Review of Biochemistry"},{"issue":"18","key":"10.1016\/j.cytogfr.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor \u03b2 in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in TGF-\u03b2 signaling through Smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"6958","key":"10.1016\/j.cytogfr.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-[beta] family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.cytogfr.2013.04.006_bib0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(00)81696-7","article-title":"Transcriptional activators of TGF-\u03b2 responses: Smads","volume":"95","author":"Derynck","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cytogfr.2013.04.006_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/35043051","article-title":"How cells read TGF-[beta] signals","volume":"1","author":"Massague","year":"2000","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ceb.2007.02.015","article-title":"Negative regulation of TGF-\u03b2 receptor\/Smad signal transduction","volume":"19","author":"Itoh","year":"2007","journal-title":"Current Opinion in Cell Biology"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/dbio.1996.0259","article-title":"TGF-\u03b2 receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis","volume":"179","author":"Oshima","year":"1996","journal-title":"Developmental Biology"},{"issue":"9","key":"10.1016\/j.cytogfr.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","article-title":"Role of transforming growth factor beta in human cancer","volume":"23","author":"Elliott","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.molcel.2004.06.007","article-title":"JNK regulates autocrine expression of TGF-\u03b21","volume":"15","author":"Ventura","year":"2004","journal-title":"Molecular Cell"},{"issue":"6489","key":"10.1016\/j.cytogfr.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/370460a0","article-title":"Activation of transforming growth factor-[beta] is inhibited in transgenic apolipoprotein(a) mice","volume":"370","author":"Grainger","year":"1994","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.cytogfr.2013.04.006_bib0070","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1242\/dev.124.13.2659","article-title":"TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes","volume":"124","author":"Sanford","year":"1997","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng1295-409","article-title":"Transforming growth factor-[beta]3 is required for secondary palate fusion","volume":"11","author":"Proetzel","year":"1995","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780903382609","article-title":"Targeting the transforming growth factor-\u03b2 signaling pathway in human cancer","volume":"19","author":"Nagaraj","year":"2010","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/oli.2006.0053","article-title":"Inhibition of TGF-2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I\/II studies","volume":"17","author":"Hau","year":"2007","journal-title":"Oligonucleotides"},{"issue":"16","key":"10.1016\/j.cytogfr.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.104.528695","article-title":"Angiotensin-converting enzyme inhibitors","volume":"112","author":"Peng","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.cytogfr.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1158\/0008-5472.CAN-04-0018","article-title":"Targeting endogenous transforming growth factor \u03b2 receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype 1","volume":"64","author":"Subramanian","year":"2004","journal-title":"Cancer Research"},{"issue":"8","key":"10.1016\/j.cytogfr.2013.04.006_bib0100","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1167\/iovs.02-0978","article-title":"Evaluation of anti-TGF-\u03b22 antibody as a new postoperative anti-scarring agent in glaucoma surgery","volume":"44","author":"Mead","year":"2003","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"11","key":"10.1016\/j.cytogfr.2013.04.006_bib0105","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1535-7163.MCT-12-0101-T","article-title":"Inhibition of TGF-\u03b2 enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy","volume":"11","author":"Bedi","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"issue":"6","key":"10.1016\/j.cytogfr.2013.04.006_bib0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/edrv.22.6.0450","article-title":"Activins and inhibins in endocrine and other tumors","volume":"22","author":"Risbridger","year":"2001","journal-title":"Endocrine Reviews"},{"issue":"3","key":"10.1016\/j.cytogfr.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/bbrc.1997.6162","article-title":"Genes coding for mouse activin \u03b2C and \u03b2E are closely linked and exhibit a liver-specific expression pattern in adult tissues","volume":"231","author":"Fang","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"10.1016\/j.cytogfr.2013.04.006_bib0120","first-page":"4851","article-title":"Localization of activin \u03b2A-, \u03b2 B-, and \u03b2 C-subunits in human prostate and evidence for formation of new activin heterodimers of \u03b2 C-subunit","volume":"85","author":"Mellor","year":"2000","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"10","key":"10.1016\/j.cytogfr.2013.04.006_bib0125","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/en.2003-0225","article-title":"Activin \u03b2C-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate","volume":"144","author":"Mellor","year":"2003","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Communication and Signaling"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3835(95)03689-T","article-title":"Expression of activins and activin receptors in human retinoblastoma cell line Y-79","volume":"89","author":"Zhang","year":"1995","journal-title":"Cancer Letters"},{"issue":"5","key":"10.1016\/j.cytogfr.2013.04.006_bib0140","first-page":"1155","article-title":"Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells","volume":"56","author":"Liu","year":"1996","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1006\/bbrc.1993.2576","article-title":"Activin A induces apoptotic cell death","volume":"197","author":"Nishihara","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"31","key":"10.1016\/j.cytogfr.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"23066","DOI":"10.1016\/S0021-9258(19)49426-X","article-title":"Inhibition of vascular endothelial cell growth by activin-A","volume":"268","author":"McCarthy","year":"1993","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/excr.1993.1131","article-title":"Modulation of growth of vascular smooth muscle cells by activin A","volume":"206","author":"Kojima","year":"1993","journal-title":"Experimental Cell Research"},{"issue":"11","key":"10.1016\/j.cytogfr.2013.04.006_bib0160","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood.V81.11.2891.2891","article-title":"Activin A suppresses proliferation of interleukin-3-responsive granulocyte\u2013macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood","volume":"81","author":"Mizuguchi","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1095\/biolreprod59.4.807","article-title":"Characterization of inhibin\/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes","volume":"59","author":"Sidis","year":"1998","journal-title":"Biology of Reproduction"},{"issue":"10","key":"10.1016\/j.cytogfr.2013.04.006_bib0170","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0898-6568(98)00021-7","article-title":"The role of activin type I receptors in activin A-induced growth arrest and apoptosis in mouse B-cell hybridoma cells","volume":"10","author":"Hashimoto","year":"1998","journal-title":"Cellular Signalling"},{"issue":"17","key":"10.1016\/j.cytogfr.2013.04.006_bib0175","first-page":"3929","article-title":"The bright and the dark sides of activin in wound healing and cancer","volume":"125","author":"Antsiferova","year":"2012","journal-title":"Journal of Cell Science"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tem.2005.01.003","article-title":"Antagonists of activin signaling: mechanisms and potential biological applications","volume":"16","author":"Harrison","year":"2005","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/j.cytogfr.2013.04.006_bib0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/153537020222700201","article-title":"Regulation of cell proliferation, apoptosis, and carcinogenesis by activin","volume":"227","author":"Chen","year":"2002","journal-title":"Experimental Biology and Medicine"},{"issue":"6277","key":"10.1016\/j.cytogfr.2013.04.006_bib0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/345729a0","article-title":"Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A","volume":"345","author":"Smith","year":"1990","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cytogfr.2013.04.006_bib0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(92)90550-V","article-title":"Responses of embryonic xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm","volume":"71","author":"Green","year":"1992","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/mcne.1999.0806","article-title":"Activin A promotes progenitor differentiation into photoreceptors in rodent retina","volume":"15","author":"Davis","year":"2000","journal-title":"Molecular and Cellular Neuroscience"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0205","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2007.07.200","article-title":"Activin B mediated induction of Pdx1 in human embryonic stem cell derived embryoid bodies","volume":"362","author":"Frandsen","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"15","key":"10.1016\/j.cytogfr.2013.04.006_bib0210","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1101\/gad.14.15.1866","article-title":"Activin receptor patterning of foregut organogenesis","volume":"14","author":"Kim","year":"2000","journal-title":"Genes & Development"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0215","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1242\/jcs.012450","article-title":"Activin increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics","volume":"120","author":"Shoji-Kasai","year":"2007","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cne.20197","article-title":"Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures","volume":"476","author":"Foster","year":"2004","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0006-8993(99)01638-8","article-title":"Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic\u2013ischemic brain injury in the infant rat","volume":"835","author":"Wu","year":"1999","journal-title":"Brain Research"},{"issue":"Suppl. 1","key":"10.1016\/j.cytogfr.2013.04.006_bib0230","first-page":"S35","article-title":"Elucidation of the role of activin in organogenesis using a multiple organ induction system with amphibian and mouse undifferentiated cells in vitro","volume":"50","author":"Asashima","year":"2008","journal-title":"Development, Growth & Differentiation"},{"issue":"6","key":"10.1016\/j.cytogfr.2013.04.006_bib0235","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1634\/stemcells.2005-0299","article-title":"Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells","volume":"24","author":"Xiao","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0240","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.stem.2008.07.001","article-title":"NANOG is a direct target of TGFbeta\/activin-mediated SMAD signaling in human ESCs","volume":"3","author":"Xu","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"Suppl. 1(0)","key":"10.1016\/j.cytogfr.2013.04.006_bib0245","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ejphar.2011.07.007","article-title":"Anti-inflammatory therapies in cancer cachexia","volume":"668","author":"Argil\u00e9s","year":"2011","journal-title":"European Journal of Pharmacology"},{"issue":"6402","key":"10.1016\/j.cytogfr.2013.04.006_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/360313a0","article-title":"[alpha]-Inhibin is a tumour-suppressor gene with gonadal specificity in mice","volume":"360","author":"Matzuk","year":"1992","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cytogfr.2013.04.006_bib0255","first-page":"534","article-title":"Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice","volume":"10","author":"Coerver","year":"1996","journal-title":"Molecular Endocrinology"},{"issue":"10","key":"10.1016\/j.cytogfr.2013.04.006_bib0260","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1210\/me.2007-0147","article-title":"SMAD3 regulates gonadal tumorigenesis","volume":"21","author":"Li","year":"2007","journal-title":"Molecular Endocrinology"},{"issue":"7","key":"10.1016\/j.cytogfr.2013.04.006_bib0265","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1210\/endo.141.7.7535","article-title":"Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice","volume":"141","author":"Cipriano","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0365","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/path.4142","article-title":"Activin-\u03b2c reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice","volume":"229","author":"Gold","year":"2013","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-\u03b2 superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"10.1016\/j.cytogfr.2013.04.006_bib0280","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.65.3.744","article-title":"SB-505124 is a selective inhibitor of transforming growth factor-\u03b2 type I receptors ALK4, ALK5, and ALK7","volume":"65","author":"DaCosta Byfield","year":"2004","journal-title":"Molecular Pharmacology"},{"issue":"27","key":"10.1016\/j.cytogfr.2013.04.006_bib0285","doi-asserted-by":"crossref","first-page":"28036","DOI":"10.1074\/jbc.M402782200","article-title":"An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors","volume":"279","author":"Harrison","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0290","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1210\/endo.140.4.6665","article-title":"Activin and inhibin binding to the soluble extracellular domain of activin receptor II","volume":"140","author":"Donaldson","year":"1999","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cytogfr.2013.04.006_bib0295","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/endo.143.3.8667","article-title":"Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo","volume":"143","author":"Leal","year":"2002","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.cytogfr.2013.04.006_bib0300","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1210\/en.2011-1052","article-title":"Generation of a specific activin antagonist by modification of the activin A propeptide","volume":"152","author":"Makanji","year":"2011","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.cytogfr.2013.04.006_bib0305","first-page":"2125","article-title":"Serum immunoreactive activin A levels in normal subjects and patients with various diseases","volume":"81","author":"Harada","year":"1996","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"11","key":"10.1016\/j.cytogfr.2013.04.006_bib0310","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1210\/jcem.82.11.4374","article-title":"Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer","volume":"82","author":"Thomas","year":"1997","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0315","first-page":"1194","article-title":"Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma","volume":"83","author":"Petraglia","year":"1998","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/gyno.2001.6350","article-title":"Production of activin A in hyperplasia and adenocarcinoma of the human endometrium","volume":"83","author":"Otani","year":"2001","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1016\/j.cytogfr.2013.04.006_bib0325","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.49.3.409","article-title":"Overexpression of activin A in stage IV colorectal cancer","volume":"49","author":"Wildi","year":"2001","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cytogfr.2013.04.006_bib0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"Costelli","year":"2008","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0335","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1093\/jn\/129.1.227S","article-title":"Muscle protein breakdown and the critical role of the ubiquitin\u2013proteasome pathway in normal and disease states","volume":"129","author":"Lecker","year":"1999","journal-title":"The Journal of Nutrition"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2353\/ajpath.2009.080296","article-title":"Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo","volume":"174","author":"Gold","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0345","article-title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","author":"Attie","year":"2012","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/j.cytogfr.2013.04.006_bib0350","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-[beta] superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7","volume":"62","author":"Inman","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.cytogfr.2013.04.006_bib0360","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1101\/gad.1041203","article-title":"EGF-CFC proteins are essential coreceptors for the TGF-\u03b2 signals Vg1 and GDF1","volume":"17","author":"Cheng","year":"2003","journal-title":"Genes & Development"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0370","first-page":"211","volume":"vol. 95","author":"Vale","year":"1990"},{"issue":"38","key":"10.1016\/j.cytogfr.2013.04.006_bib0375","doi-asserted-by":"crossref","first-page":"24293","DOI":"10.1074\/jbc.273.38.24293","article-title":"Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells","volume":"273","author":"Ishisaki","year":"1998","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.cytogfr.2013.04.006_bib0380","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","article-title":"Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice","volume":"91","author":"Matzuk","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:53:39Z","timestamp":1761216819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610113000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1359610113000348"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.04.006","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of blocking the activin signalling pathway","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}